ELIZABETH ELIOPOULOS: Open Payments
NPI 1043969454 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$256 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $256
Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $110 |
| Lilly USA, LLC | 1 | $24 |
| Calliditas Therapeutics US Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Vifor Pharma, Inc. | 1 | $21 |
| Travere Therapeutics, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: JYNARQUE, VOYXACT, JARDIANCE, TARPEYO, Kerendia, Veltassa, TAVNEOS, FARXIGA.
Industry payments across MO — which companies pay providers there.
